• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估与细菌性阴道病和腹膜炎相关厌氧菌的抗菌谱及效价测定的Etest法

Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis.

作者信息

Croco J L, Erwin M E, Jennings J M, Putnam L R, Jones R N

机构信息

Department of Pathology, University of Iowa College of Medicine, Iowa City 52242.

出版信息

Diagn Microbiol Infect Dis. 1994 Dec;20(4):213-9. doi: 10.1016/0732-8893(94)90006-x.

DOI:10.1016/0732-8893(94)90006-x
PMID:7705035
Abstract

One hundred ninety-seven anaerobic organisms (24 Gardnerella vaginalis, 16 Mobiluncus spp., 19 Peptostreptococcus spp., 20 Lactobacillus spp., 20 Prevotella bivia/disiens, 81 Bacteroides fragilis group, 12 Clostridium spp., and five Fusobacterium spp.) were processed by the Etest (AB Biodisk, Solna, Sweden) and a reference (Brucella blood agar) method against 10 antimicrobial agents. For the bacterial vaginosis-associated pathogens, the Etest was more reproducible and correlated acceptably with the reference agar test: within +/- 1 log2 dilution for 74.4% of Mobiluncus spp. to 96.0% for Peptostreptococcus spp. (all organisms, 83.4%). The quantitative correlation +/- 2 log2 dilution steps between test results was 94.3%. Results with B. fragilis group strains demonstrated 97.3% correlation (+/- 2 log2 dilution) with a trend toward slightly lower Etest minimum inhibitory concentrations for ampicillin-sulbactam, cefotaxime, imipenem, and clindamycin. The absolute qualitative interpretive agreement between Etest and the reference agar dilution method results was 94.4%, with only a 0.4% false-susceptible error rate. The Etest appears to be a very practical, quantitatively accurate, alternative procedure for clinical microbiology laboratories routinely testing the susceptibilities of anaerobes and, by these presented data, organisms associated with female tract infections.

摘要

采用Etest法(AB生物盘公司,瑞典索尔纳)和参考方法(布鲁氏菌血琼脂),针对10种抗菌药物对197株厌氧菌(24株阴道加德纳菌、16株动弯杆菌属、19株消化链球菌属、20株乳杆菌属、20株二路普雷沃菌/双路普雷沃菌、81株脆弱拟杆菌群、12株梭菌属和5株具核梭杆菌)进行了检测。对于与细菌性阴道病相关的病原体,Etest法的重复性更好,与参考琼脂试验的相关性也可接受:动弯杆菌属的74.4%至消化链球菌属的96.0%(所有菌株为83.4%)在±1个log2稀释度范围内。检测结果之间±2个log2稀释度步骤的定量相关性为94.3%。脆弱拟杆菌群菌株的结果显示相关性为97.3%(±2个log2稀释度),对于氨苄西林 - 舒巴坦、头孢噻肟、亚胺培南和克林霉素,Etest法的最低抑菌浓度有略低的趋势。Etest法与参考琼脂稀释法结果的绝对定性解释一致性为94.4%,假敏感错误率仅为0.4%。对于临床微生物实验室常规检测厌氧菌以及根据这些数据检测与女性生殖道感染相关的病原体,Etest法似乎是一种非常实用、定量准确的替代方法。

相似文献

1
Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis.用于评估与细菌性阴道病和腹膜炎相关厌氧菌的抗菌谱及效价测定的Etest法
Diagn Microbiol Infect Dis. 1994 Dec;20(4):213-9. doi: 10.1016/0732-8893(94)90006-x.
2
Evaluation of the Etest for susceptibility testing of anaerobic bacteria.
Diagn Microbiol Infect Dis. 1995 Jul;22(3):279-84. doi: 10.1016/0732-8893(95)00049-g.
3
[Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].[从各种临床标本中分离出的厌氧细菌的鉴定及抗生素敏感性测定]
Mikrobiyol Bul. 2010 Apr;44(2):211-9.
4
[Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].[Etest法在专性厌氧菌抗菌药物敏感性试验中的应用]
Med Dosw Mikrobiol. 2001;53(2):167-75.
5
Susceptibility of anaerobic bacteria in Auckland: 1991-1996.奥克兰地区厌氧菌的药敏情况:1991 - 1996年
N Z Med J. 1999 Nov 12;112(1099):424-6.
6
[Role of Gardnerella vaginalis and anaerobes. Etiology of nonspecific colpitis].
Fortschr Med. 1984 Mar 15;102(10):255-8.
7
Evaluation of the Etest for determinations of antimicrobial spectrum and potency against anaerobes associated with bacterial vaginosis and peritonitis.评估Etest法用于测定与细菌性阴道病和腹膜炎相关厌氧菌的抗菌谱及效力。
Clin Infect Dis. 1995 Jun;20 Suppl 2:S339-41. doi: 10.1093/clinids/20.supplement_2.s339.
8
Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.1999 - 2003年新西兰厌氧菌的抗菌药敏性
J Antimicrob Chemother. 2006 May;57(5):992-8. doi: 10.1093/jac/dkl052. Epub 2006 Feb 28.
9
Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.韩国厌氧菌对抗菌药物的新出现耐药性。
Clin Infect Dis. 1996 Dec;23 Suppl 1:S73-7. doi: 10.1093/clinids/23.supplement_1.s73.
10
Antimicrobial susceptibilities of clinical isolates of the anaerobic bacteria which can cause aspiration pneumonia.可引起吸入性肺炎的厌氧细菌临床分离株的抗菌药敏试验结果。
Anaerobe. 2019 Jun;57:86-89. doi: 10.1016/j.anaerobe.2019.04.002. Epub 2019 Apr 2.

引用本文的文献

1
Broth Microdilution and Gradient Diffusion Strips vs. Reference Agar Dilution Method: First Evaluation for Species Antimicrobial Susceptibility Testing.肉汤微量稀释法和梯度扩散条带法与参考琼脂稀释法的比较:首次用于菌种抗菌药敏试验的评估
Antibiotics (Basel). 2021 Aug 12;10(8):975. doi: 10.3390/antibiotics10080975.
2
Antianaerobic antimicrobials: spectrum and susceptibility testing.抗厌氧微生物药物:谱和药敏试验。
Clin Microbiol Rev. 2013 Jul;26(3):526-46. doi: 10.1128/CMR.00086-12.
3
First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species.
首次全面评估 M.I.C. 评估器设备与 Etest 和 CLSI 参考稀释方法在厌氧菌和其他苛养细菌临床分离株的抗菌药物敏感性测试中的比较。
J Clin Microbiol. 2012 Apr;50(4):1153-7. doi: 10.1128/JCM.05397-11. Epub 2012 Jan 11.
4
Antibiotic susceptibility of Atopobium vaginae.阴道阿托波菌的抗生素敏感性
BMC Infect Dis. 2006 Mar 16;6:51. doi: 10.1186/1471-2334-6-51.
5
Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.用于乳酸杆菌、片球菌、乳球菌和双歧杆菌微量稀释抗生素敏感性试验的新型肉汤培养基的评估
Appl Environ Microbiol. 2005 Dec;71(12):8982-6. doi: 10.1128/AEM.71.12.8982-8986.2005.
6
Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status.乳酸杆菌属菌种鉴定、过氧化氢产生情况、抗生素耐药性及其与人类临床状况的相关性。
J Clin Microbiol. 1999 Mar;37(3):729-33. doi: 10.1128/JCM.37.3.729-733.1999.
7
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.头孢噻肟。对其抗菌活性和药代动力学特性的重新评估,以及对其每日两次给药治疗轻至中度感染时的治疗效果的综述。
Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009.